Drug development output from 1975 to 1996: what proportion for tropical diseases?
Trouiller, P.; Olliaro, P.L.
International Journal of Infectious Diseases Ijid Official Publication of the International Society for Infectious Diseases 3(2): 61-63
1998
ISSN/ISBN: 1201-9712 PMID: 10225981 DOI: 10.1016/s1201-9712(99)90010-3Document Number: 532902
Document emailed within 0-6 h
Related Documents
Sumarokov, A.V.; Mikhaĭlov, A.A.; Danil'chenko, M.A. 1971: Role of cardiac output in the development of the hypertensive syndrome in chronic parenchymal diseases of the kidneys Kardiologiia 11(10): 65-69Allotey, P.; Reidpath, D.D.; Pokhrel, S. 2010: Social sciences research in neglected tropical diseases 1: the ongoing neglect in the neglected tropical diseases Health Research Policy and Systems 8: 32
Kornchankul, W.; Hamed, E.; Parikh, N.H.; Sakr, A. 2002: Effect of drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer Die Pharmazie 57(1): 49-53
Tabberer, M.; Jones, P.W. 2017: The COPD Biomarkers Qualification Consortium St George's Respiratory Questionnaire Manuscripts: Output of a Consortium to Advance Drug Development Chronic Obstructive Pulmonary Diseases 4(2): 109-111
Parker, M.; Allen, T. 2011: Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda Health Research Policy and Systems 9: 3
Cooper, P.J.; Chico, M.E.; Guadalupe, I.; Sandoval, C.A.; Mitre, E.; Platts-Mills, T.A.E.; Barreto, M.L.; Rodrigues, L.C.; Strachan, D.P.; Griffin, G.E. 2011: Impact of early life exposures to geohelminth infections on the development of vaccine immunity, allergic sensitization, and allergic inflammatory diseases in children living in tropical Ecuador: the ECUAVIDA birth cohort study Bmc Infectious Diseases 11: 184
Croft, S.L. 2007: Neglected diseases: progress in drug development Current Opinion in Investigational Drugs 8(2): 103-104
Bjorn, A.; Declercqlopez, L.; Spatari, S.; Maclean, H.L. 2005: Decision support for sustainable development using a canadian economic input-output life cycle assessment model : Sustainable development - Sustainable development Canadian Journal of Civil Engineering 32(1): 16-29
Bjorn, A.; Declercqlopez, L.; Spatari, S.; Maclean, H.L. 2005: Decision support for sustainable development using a canadian economic input-output life cycle assessment model : Sustainable development - Sustainable development Canadian Journal of Civil Engineering 32(1): 16-29
Bjorn, A.; Declercqlopez, L.; Spatari, S.; Maclean, H.L. 2005: Decision support for sustainable development using a canadian economic input-output life cycle assessment model : Sustainable development - Sustainable development Canadian Journal of Civil Engineering 32(1): 16-29
Bjorn, A.; Declercqlopez, L.; Spatari, S.; Maclean, H.L. 2005: Decision support for sustainable development using a canadian economic input-output life cycle assessment model : Sustainable development - Sustainable development Canadian Journal of Civil Engineering 32(1): 16-29
Bjorn, A.; Declercqlopez, L.; Spatari, S.; Maclean, H.L. 2005: Decision support for sustainable development using a canadian economic input-output life cycle assessment model : Sustainable development - Sustainable development Canadian Journal of Civil Engineering 32(1): 16-29
Bjorn, A.; Declercqlopez, L.; Spatari, S.; Maclean, H.L. 2005: Decision support for sustainable development using a canadian economic input-output life cycle assessment model : Sustainable development - Sustainable development Canadian Journal of Civil Engineering 32(1): 16-29
Bjorn, A.; Declercqlopez, L.; Spatari, S.; Maclean, H.L. 2005: Decision support for sustainable development using a canadian economic input-output life cycle assessment model : Sustainable development - Sustainable development Canadian Journal of Civil Engineering 32(1): 16-29
Fodor, T.; Tusnády, G. 1971: Note on the statistical aspects of the proportion method for determining the drug-resistance of tubercle bacilli Scandinavian Journal of Respiratory Diseases 52(4): 212-216
Miyata, Y.; Shimomura, I. 2016: Vitamin D, obesity, and diabetes:new technology toward drug development against metabolic diseases Clinical Calcium 26(3): 385-391
Mitarai, S.; Kobayashi, I.; Abe, C.; Wada, M.; Suzuki, K.; Takashima, T.; Kawabe, Y.; Machida, K.; Tano, M.; Takigawa, S.; Kamada, A.; Shigetoh, E.; Fujii, S.; Mori, K.; Suyama, H.; Yano, S.; Kawashiro, T.; Ogata, H. 2007: Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid Kekkaku: 82(5): 449-454
Whitehouse, P.J.; Sciulli, C.G.; Mason, R.M. 1997: Dementia drug development: use of information systems to harmonize global drug development Psychopharmacology Bulletin 33(1): 129-133
Allen, T.; Parker, M. 2011: The "other diseases" of the Millennium Development Goals: rhetoric and reality of free drug distribution to cure the poor's parasites Third World Quarterly 32(1): 91-117
Pettersson, T. 1971: Tropical diseases Duodecim; Laaketieteellinen Aikakauskirja 87(5): 348-354